Eczema News and Research RSS Feed - Eczema News and Research

Eczema or atopic dermatitis is a long-lasting, itchy inflammatory condition of the skin which may become red, dry, blistered, crusted, scaly or thickened.

Eczema can affect any part of the skin but most commonly manifests in parts of the body where skin folds are found such as the elbows or backs of the knees. The cause of eczema is not yet known but it is thought to involve an inherited tendency towards sensitive skin.

Although eczema can flare up for no apparent reason, sufferers may notice particular triggers that seem to worsen their condition. Some common examples are allergens such as pollen, house dust mites or pet fur, irritants such as detergents and soaps and rough clothing fabrics such as wool. Rarely, certain foods such as milk, eggs, wheat or nuts may trigger a flare-up.

Although eczema cannot be cured, it can be controlled by avoiding any known triggers of the condition. A range of medications are also available to help control symptoms and emollients in the form of creams, lotions, or oils can prevent dehydration of the skin and help it repair as well as relieving itchiness.

In the UK, up to 20% of children and up to 10% of adults have eczema and the condition is equally common in men and women.
Metvix PDT now available at Odette Cancer Centre as additional treatment option for NMSC patients

Metvix PDT now available at Odette Cancer Centre as additional treatment option for NMSC patients

The Odette Cancer Centre at Sunnybrook Health Sciences Centre in conjunction with Galderma Canada are pleased to announce that Metvix PDT (Photodynamic Therapy), is now available at the Odette Cancer Centre in Toronto as an additional treatment option for patients with NMSC (non-melanoma skin cancer). [More]
New diagnostic procedure helps differentiate psoriasis from eczema

New diagnostic procedure helps differentiate psoriasis from eczema

In some patients, the chronic inflammatory skin diseases psoriasis* and eczema** are similar in appearance. Up to now, dermatologists have therefore had to base their decision on which treatment should be selected on their own experience and an examination of tissue samples. [More]
Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema. [More]
Study gives parents, doctors new options to treat children with eczema

Study gives parents, doctors new options to treat children with eczema

The number of children with atopic dermatitis, often referred to as eczema, is on the rise. Some estimate that one in five children in the U.S. now suffers from the painful, itchy skin condition. In an effort to control their symptoms, many children are prescribed powerful medications like immunosuppressants or topical steroids. [More]
Celsus’ expert highlights serious side effects of topical corticosteroids

Celsus’ expert highlights serious side effects of topical corticosteroids

A 2013 Mayo Clinic study involving more than 140,000 patients revealed that skin disorders are the most common nonacute reason Americans seek health care. [More]
Single-cell genomics study confirms that immune cells produce steroids

Single-cell genomics study confirms that immune cells produce steroids

Researchers at the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute have discovered that some immune cells turn themselves off by producing a steroid. [More]
New research reveals that eczema may lower skin cancer risk

New research reveals that eczema may lower skin cancer risk

Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin. [More]
Drug that blocks LTA4 hydrolase enzyme plays key role in body's inflammatory response

Drug that blocks LTA4 hydrolase enzyme plays key role in body's inflammatory response

There have been great expectations regarding the production of a drug to block the enzyme LTA4 hydrolase, which plays a key role in the body's inflammatory response. [More]
Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals Inc., a joint venture with TFS Corporation Ltd., of Australia (ASX: TFC) is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of a number of over-the-counter (OTC) dermatology products containing TFS' sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO). [More]
New research identifies raised risk of self-harm among patients with certain physical illnesses

New research identifies raised risk of self-harm among patients with certain physical illnesses

New research quantifying the risk of admission to hospital for self-harm has identified a raised risk of self-harm among groups of patients with certain physical illnesses. While it is known that psychiatric illnesses are associated with a greatly elevated risk of self-harm, a moderately elevated risk was seen with common physical illnesses such as diabetes, epilepsy and asthma. [More]

Dermatologist provides tips to keep skin and hair in prime condition during winter

Winter time woes extend beyond cold temperatures and sometimes gloomy weather. Your skin can react negatively to the constant temperature changes as you move indoor to outdoor for daily living activities. [More]
Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema - a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults. [More]
Low gut microbial diversity in infants' intestines can increase risk for asthma

Low gut microbial diversity in infants' intestines can increase risk for asthma

Low gut microbial diversity in the intestines of infants can increase the risk for asthma development. These are the findings of the age 7 follow-up in a multi-year study led by researchers at Linköping University in Sweden. [More]
Scientists conduct clinical trial to determine silk clothing for treatment of eczema

Scientists conduct clinical trial to determine silk clothing for treatment of eczema

Three hundred children are being recruited for a clinical trial to establish whether or not specialist silk clothing really does help in the treatment of eczema. [More]
FDA, USDA approve SALMONELEX as GRAS food processing aid against Salmonella

FDA, USDA approve SALMONELEX as GRAS food processing aid against Salmonella

FDA & USDA announced today they have approved SALMONELEX as a "GRAS" (Generally Recognized as Safe) food processing aid against Salmonella. The new product consists of natural phages against Salmonella and is produced by Micreos of The Netherlands. The company confirms that industrial scale projects with US poultry processors will start in January 2014. [More]
Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions Inc.announced that it has entered into a definitive agreement with Cangene Corporation (TSX: CNJ) under which Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis for an aggregate purchase price of $222 million. [More]
Early antibiotic use linked to asthma, not atopy

Early antibiotic use linked to asthma, not atopy

Research from the UK has found a “robust and dose-dependent” association between antibiotic use in the first 2 years of life and subsequent asthma at the age of 7 and a half years. [More]

Tips to relieve dry skin

Dry skin is a common problem during the winter and its effects can be painful - causing the skin to flake, itch, crack and even bleed. Yet dermatologists say there are ways people can find relief by implementing a few changes to their daily lives. [More]
Taking probiotics during pregnancy has no effect on asthma rate amoung infants

Taking probiotics during pregnancy has no effect on asthma rate amoung infants

Taking probiotics has health benefits but preventing childhood asthma isn't one of them, shows newly published research led by medical scientists at the University of Alberta. [More]
Maternal weight issues spell wheezing trouble for children

Maternal weight issues spell wheezing trouble for children

High maternal weight and gestational weight gain are independently associated with an increased risk for wheezing in preschool age children, a Dutch study has found. [More]